Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Pharmacokinetics Study of CD5024 1% Cream in Papulopustular Rosacea
2008-002679-29Phase 2Completed
- Sponsor
- Galderma
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ivermectin in papulopustular rosacea, sponsored by Galderma. Started May 2008; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2008-002679-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002679-29.